title: Endothelial progenitor cells, late stent thrombosis and delayed re-endothelialisation.
abstract: A decade ago, the description of a primitive novel cell type capable of differentiating into cells expressing a mature endothelial cell -phenotype and their capacity to incorporate into regions of active angiogenesis, witnessed the emergence of endothelial progenitor cell (EPC) biology1. The development and maturation of this new concept in vascular biology has resulted in numerous studies describing the role of EPCs in a myriad of disease states where abnormalities of the vasculature have been implicated. Thus, from pre-eclampsia to pulmonary hypertension, erythropoietin administration to erectile dysfunction and cancer to coronary disease the discovery of EPCs has added greatly to the understanding of basic pathophysiology. However, it is in the study of coronary artery -disease where this paradigm shift has had greatest impact, not only regarding basic disease mechanisms, but in the rapid translation of these findings into a clinical context. The purpose of this review is to outline the current understanding of the EPC phenotypes and their relationship with risk factors for coronary disease. In addition, the potential problems of EPC dysfunction and its impact on percutaneous intervention will be appraised together with both pharmacological and stent based strategies to augment EPC -number and function.
authors.affiliation: Department of Cardiology, King's College Hospital, Denmark Hill, London, United Kingdom.
authors.forename: Rohit
authors.initials: R
authors.lastname: Khurana
authors.forename: Manuel
authors.initials: M
authors.lastname: Mayr
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Hill